-
If you purchased shares of Bristol-Myers Squibb Co (NYSE:BMY) and currently hold any of those NYSE:BMY shares, you have certain options and you should contact the Shareholders Foundation, Inc.
-
To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Investigation Overview
August 23, 2016 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Bristol-Myers Squibb Co (NYSE:BMY) was announced over potential breaches of fiduciary duties by certain officers and directors at Bristol-Myers Squibb.
The investigation by a law firm concerns whether certain Bristol-Myers Squibb Co officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
In October 2015, Bristol-Myers Squibb Co reached a civil settlement with the Securities and exchange Commission (SEC) of alleged Foreign Corrupt Practices Act (FCPA) violations in which the Company agreed to approximately $14.7 million in disgorgement, penalties and interest.
Bristol-Myers Squibb Co reported that its annual Total Revenue rose from over $15.87 billion in 2014 to over $16.56 billion in 2015 while its Net Income declined from over $2 billion in 2014 to over $1.56 billion in 2015.
Shares of Bristol-Myers Squibb Co (NYSE:BMY) declined from $76.30 per share on August 1, 2016 to as low as $58.07 per share on August 17, 2016.
